These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29868882)

  • 1. In silico clinical trials: concepts and early adoptions.
    Pappalardo F; Russo G; Tshinanu FM; Viceconti M
    Brief Bioinform; 2019 Sep; 20(5):1699-1708. PubMed ID: 29868882
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Jose J; S S; Mathew B; Parambi DGT
    Comb Chem High Throughput Screen; 2022; 25(12):1991-2000. PubMed ID: 34986768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Credibility of In Silico Trial Technologies-A Theoretical Framing.
    Viceconti M; Juarez MA; Curreli C; Pennisi M; Russo G; Pappalardo F
    IEEE J Biomed Health Inform; 2020 Jan; 24(1):4-13. PubMed ID: 31670687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies.
    Viceconti M; Cobelli C; Haddad T; Himes A; Kovatchev B; Palmer M
    Proc Inst Mech Eng H; 2017 May; 231(5):455-466. PubMed ID: 28427321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico modelling of physiologic systems.
    Colquitt RB; Colquhoun DA; Thiele RH
    Best Pract Res Clin Anaesthesiol; 2011 Dec; 25(4):499-510. PubMed ID: 22099916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products.
    Viceconti M; Pappalardo F; Rodriguez B; Horner M; Bischoff J; Musuamba Tshinanu F
    Methods; 2021 Jan; 185():120-127. PubMed ID: 31991193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico trials for treatment of acute ischemic stroke: Design and implementation.
    Miller C; Padmos RM; van der Kolk M; Józsa TI; Samuels N; Xue Y; Payne SJ; Hoekstra AG
    Comput Biol Med; 2021 Oct; 137():104802. PubMed ID: 34520989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing drug development in oncology by clinical trial simulation: Why and how?
    Gal J; Milano G; Ferrero JM; Saâda-Bouzid E; Viotti J; Chabaud S; Gougis P; Le Tourneau C; Schiappa R; Paquet A; Chamorey E
    Brief Bioinform; 2018 Nov; 19(6):1203-1217. PubMed ID: 28575140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Care Efficiencies: Consolidation and Alternative Models vs. Health Care and Antitrust Regulation - Irreconcilable Differences?
    King MW
    Am J Law Med; 2017 Nov; 43(4):426-467. PubMed ID: 29452560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Way to New Horizons: Telemedicine in Oncology.
    Schlag PM
    Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Contexts of Use for In Silico Trials Methodologies: A Consensus-Based Review.
    Viceconti M; Emili L; Afshari P; Courcelles E; Curreli C; Famaey N; Geris L; Horner M; Jori MC; Kulesza A; Loewe A; Neidlin M; Reiterer M; Rousseau CF; Russo G; Sonntag SJ; Voisin EM; Pappalardo F
    IEEE J Biomed Health Inform; 2021 Oct; 25(10):3977-3982. PubMed ID: 34161248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.
    Fraser AG; Daubert JC; Van de Werf F; Estes NA; Smith SC; Krucoff MW; Vardas PE; Komajda M;
    Eur Heart J; 2011 Jul; 32(13):1673-86. PubMed ID: 21572115
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.